Yanyu Wang
- Topics
- Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers)Pancreatic and Hepatic Oncology Research (7 papers)Monoclonal and Polyclonal Antibodies Research (6 papers)
- Cited by
- HepatologyOncologyCancer Research
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yanyu Wang
45 papers receiving 438 citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 166
- Surgery 151
- Molecular Biology 81
- Pulmonary and Respiratory Medicine 78
- Cancer Research 53
Countries citing papers authored by Yanyu Wang
This map shows the geographic impact of Yanyu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanyu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanyu Wang more than expected).
Fields of papers citing papers by Yanyu Wang
This network shows the impact of papers produced by Yanyu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanyu Wang. The network helps show where Yanyu Wang may publish in the future.
Co-authorship network of co-authors of Yanyu Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Yanyu Wang. A scholar is included among the top collaborators of Yanyu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanyu Wang. Yanyu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinomabreakdown → | 43 |
| 4 | 0 | |
| 5 | 5 | |
| 6 | 26 | |
| 7 | 7 | |
| 8 | 6 | |
| 9 | 2 | |
| 10 | 16 | |
| 11 | 32 | |
| 12 | 5 | |
| 13 | 20 | |
| 14 | 30 | |
| 15 | 12 | |
| 16 | 9 | |
| 17 | 7 | |
| 18 | 5 | |
| 19 | 1 | |
| 20 | 6 |
About Yanyu Wang
Yanyu Wang is a scholar working on Hepatology, Oncology and Hematology, having authored 46 papers that have together received 441 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Hepatology (51 citations), Oncology (166 citations) and Cancer Research (53 citations). Yanyu Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Haitao Zhao, Xinting Sang, Xiaobo Yang, Ziyu Xun, Pingshuan Dong, Nan Zhang, Yunchao Wang, Yunchao Wang, Junyu Long and Xu Yang. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.